Acute Viral Hepatitis Recovery Support Protocol

Acute viral hepatitis is inflammation of the liver caused by hepatitis viruses (A, B, C, D, or E). Hepatitis A and E typically cause self-limited illness, while hepatitis B and C can become chronic. Symptoms include fatigue, nausea, abdominal pain, dark urine, pale stools, and jaundice (yellowing of skin and eyes). Most cases of acute viral hepatitis resolve on their own with supportive care, but liver function should be monitored.

CRITICAL: Acute viral hepatitis requires medical diagnosis and monitoring. The type of hepatitis virus determines management - hepatitis B may need antiviral treatment to prevent chronicity, and hepatitis C now has highly effective antiviral cures. Liver enzymes (ALT, AST) and coagulation should be monitored. Severe hepatitis (coagulopathy, encephalopathy) requires hospitalization. Avoid alcohol completely during recovery. These supplements support liver health but don't treat the viral infection itself.

* Milk Thistle (Silymarin) is the most studied hepatoprotective herb. It stabilizes liver cell membranes, acts as an antioxidant, promotes liver cell regeneration, and has anti-inflammatory effects. It's been used for centuries for liver conditions.

* N-Acetyl Cysteine (NAC) is a precursor to glutathione, the liver's primary antioxidant. It supports the liver's detoxification capacity and protects against oxidative damage during inflammation.

* Kutki is an Ayurvedic herb traditionally used for liver disorders. It has hepatoprotective properties and may help reduce liver inflammation.

* Schisandra is an adaptogenic berry used in Traditional Chinese Medicine for liver support. It may help protect liver cells and support regeneration.

* Vitamin E protects liver cells from oxidative damage, which is increased during active hepatitis.

* Vitamin C provides additional antioxidant support and supports immune function.

* Zinc is often depleted in liver disease and supports immune function and liver metabolism.

* B Vitamins support liver metabolism and energy production. The liver needs B vitamins for numerous metabolic functions.

Expected timeline: Acute hepatitis A and E typically resolve in 2-6 weeks. Hepatitis B acute phase lasts weeks to months - 95% of adults clear the virus. These supplements support recovery but don't accelerate viral clearance. Liver enzymes should normalize within 1-4 months of symptom onset.

Clinical Perspective

Acute viral hepatitis: liver inflammation from hepatitis viruses. Hepatitis A: fecal-oral, self-limited, no chronic state. Hepatitis B: blood/body fluids, 5% chronicity in adults, higher in neonates. Hepatitis C: blood-borne, 75-85% chronicity, now curable with DAAs. Hepatitis D: requires HBV co-infection. Hepatitis E: fecal-oral, self-limited (except immunocompromised, pregnant). Presentation: prodrome (fatigue, anorexia, nausea) → icteric phase (jaundice, dark urine, pale stools) → convalescent phase.

CRITICAL: Diagnosis requires serology (anti-HAV IgM, HBsAg, anti-HBc IgM, anti-HCV, HCV RNA). Management depends on virus type. HAV/HEV: supportive care. Acute HBV: monitor, antivirals if severe or protracted. Acute HCV: monitor for spontaneous clearance 12-16 weeks; treat with DAAs if persists. Monitor for acute liver failure (INR >1.5, encephalopathy). AVOID alcohol, hepatotoxic drugs. Supplements are ADJUNCTIVE to medical care.

* Milk Thistle (Silymarin) (B-grade): Flavonolignans; antioxidant, anti-inflammatory, hepatoprotective. Cochrane review: may benefit viral hepatitis (PMID: 26461178). Systematic review: supports use (PMID: 28246766). 420-600mg silymarin daily in divided doses.

* NAC (B-grade): Glutathione precursor; antioxidant, supports detoxification. Systematic review: hepatoprotective effects (PMID: 28578427). 600-1200mg BID.

* Kutki (Picrorhiza kurroa) (C-grade): Iridoid glycosides; hepatoprotective. Clinical trial: improved liver function in viral hepatitis (PMID: 22981502). 400-600mg extract daily.

* Schisandra (C-grade): Lignans; hepatoprotective, adaptogenic. Review: liver protection mechanisms (PMID: 23772477). 500-1000mg extract daily.

* Vitamin E (C-grade): Lipid-soluble antioxidant. Systematic review: may benefit liver disease (PMID: 24993607). 400-800 IU mixed tocopherols.

* Vitamin C (C-grade): Water-soluble antioxidant, immune support. Review: role in liver function (PMID: 16005201). 500-1000mg daily.

* Zinc (C-grade): Often depleted in liver disease; immune function. Systematic review: benefits in liver disease (PMID: 25715412). 15-30mg daily.

* B Vitamins (C-grade): Metabolic cofactors. Review: role in liver disease (PMID: 25668747). B-complex daily. Avoid high-dose niacin (hepatotoxic).

Biomarker targets: ALT/AST (should normalize), bilirubin, INR (if elevated, concerning), viral serology/PCR for clearance monitoring.

Protocol notes: Acute HAV: self-limited, lifelong immunity. Vaccination post-exposure for contacts. Acute HBV: 95% adult clearance; antivirals (tenofovir, entecavir) for severe/protracted. Post-exposure prophylaxis for contacts. Acute HCV: 15-25% spontaneous clearance; if HCV RNA positive at 12-16 weeks, treat with DAAs (cure rate >95%). Supportive care: rest, adequate nutrition, hydration. Avoid alcohol for 6 months minimum (longer if liver damage). Avoid acetaminophen if liver severely affected. Low-fat diet if nausea. Monitor for fulminant hepatitis: INR >1.5, encephalopathy → refer for liver transplant evaluation. Vaccination: HAV/HBV vaccines for prevention. No vaccine for HCV. Hepatitis E concerning in pregnancy (high mortality). Recovery from acute hepatitis: most fully recover; recheck liver enzymes at 3-6 months.

View All Protocols